Respicardia

company

About

Respicardia develops implantable therapies to improve respiratory and cardiovascular health.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
$27M
Industries
Health Care,Medical Device,Therapeutics
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Active

Respicardia (formerly Cardiac Concepts) is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing pattern during sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$106.50M
Respicardia has raised a total of $106.50M in funding over 2 rounds. Their latest funding was raised on Dec 19, 2017 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 19, 2017 Series Unknown $58.50M 1 Detail
Aug 25, 2010 Series C $27M 1 Detail
Oct 17, 2008 Series B $21M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Respicardia is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series Unknown